首页> 外文期刊>Cellular and molecular life sciences: CMLS >Mechanisms of resistance to xenobiotics in human therapy
【24h】

Mechanisms of resistance to xenobiotics in human therapy

机译:人类治疗中对异生物素的耐药机制

获取原文
获取原文并翻译 | 示例
           

摘要

Xenobiotic resistance is the major cause of failure in human therapies. Because of their serious clinical and economical consequences, resistance phenomena have been intensively studied in the case of antibacterial, anticancer, antipaludic and anti-human immunodeficiency virus-1 therapies. Beside pharmacological factors that can impede the action of the drugs, several cellular mechanisms of resistance have been described. Surprisingly, these mechanisms are conserved among bacteria, eucaryotic cells, parasites and viruses. The efficiency of drugs can be circumvented by alteration of the drug cellular concentration (altered influx, enhanced efflux or sequestration), detoxification, alteration of the drug target, nonactivation or inactivation of the drug, or by enhanced DNA repair.
机译:异源生物耐药性是人类疗法失败的主要原因。由于其严重的临床和经济后果,在抗菌,抗癌,抗paludic和抗人免疫缺陷病毒1疗法的情况下,对耐药现象进行了深入研究。除了可能阻碍药物作用的药理学因素外,还描述了几种抗药性的细胞机制。出乎意料的是,这些机制在细菌,真核细胞,寄生虫和病毒之间是保守的。可以通过改变药物细胞浓度(改变流入量,增加流出或隔离),解毒,改变药物靶标,使药物失活或失活或通过增强DNA修复来规避药物的效率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号